Status:
RECRUITING
Effectiveness of ECP Therapy in Stable Angina Pectoris Patients
Lead Sponsor:
Universitas Padjadjaran
Conditions:
Counterpulsation
Angina Pectoris
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
External Counterpulsation (ECP) is a non-invasive therapy using pressured cuff that is performed on patients with refractory stable angina pectoris to relieve symptoms and increase quality of life. In...
Detailed Description
Waiting time for elective CABG procedure in Indonesia is usually longer than six weeks, way longer than the European society of cardiology recommendation. During the waiting time, patients still compl...
Eligibility Criteria
Inclusion
- Age \>= 18 years old
- Diagnosed with stable angina pectoris
- Anatomic vessel disease (VD) lesion with 2VD/3VD
- Indicated for CABG and in waiting list of CABG procedure; or refuse for CABG and choose medical therapy only; or patients who are decided by the responsible doctor for medical treatment alone because of the high risks of CABG surgery.
- Not planned to urgent CABG
- Minimum optimal medical therapy within 2 weeks
- Able and willing to sign informed consent and comply with study procedures
- The patient lives in Bandung City and its neighborhood
- Retired patient; or not actively working during working hours; or willing to take the time to participate in research.
Exclusion
- Congestive Heart Failure
- Chronic heart failure with Functional Class NYHA III - IV
- LVEF \<35%
- Unprotected left main stenosis \>50%
- Blood pressure \>180/110mmHg
- Acute coronary syndrome
- Acute Heart Failure
- Severe aorta regurgitation
- Malignant arrhythmia
- Atrial fibrillation
- Premature ventricular complex
- Peripheral occlusive artery disease
- Phlebitis
- Deep vein thrombosis
- Hemorrhagic diathesis
- Severe chronic kidney disease
- Aortic aneurysm
- Abdominal aneurysm
- Osteoarthritis
- Low back pain
- Pregnancy
- Registered as other clinical study participant
Key Trial Info
Start Date :
July 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
84 Patients enrolled
Trial Details
Trial ID
NCT04873687
Start Date
July 1 2023
End Date
December 1 2026
Last Update
September 25 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dr. Hasan Sadikin General Hospital
Bandung, West Java, Indonesia, 40161